Circular RNAs as novel biomarkers in glomerular diseases

被引:1
|
作者
Hejazian, Seyyedeh Mina [1 ]
Saadat, Yalda Rahbar [1 ]
Khatibi, Seyed Mahdi Hosseiniyan [1 ]
Farnood, Farahnoosh [1 ]
Farzamikia, Negin [1 ]
Hejazian, Seyyed Sina [2 ,3 ]
Batoumchi, Sepideh [1 ]
Shoja, Mohammadali M. [4 ]
Vahed, Sepideh Zununi [1 ]
Ardalan, Mohammadreza [1 ]
机构
[1] Tabriz Univ Med Sci, Kidney Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[4] Nova Southeastern Univ, Coll Allopath Med, Ft Lauderdale, FL USA
关键词
Circular RNAs; glomerulopathy; long non-coding RNAs; glomerulus; kidney; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; TUBULAR EPITHELIAL-CELLS; HIGH GLUCOSE; NEPHROPATHY; EXPRESSION; BIOGENESIS; EXOSOMES; FIBROSIS; INJURY; GLOMERULONEPHRITIS;
D O I
10.1080/13813455.2023.2212328
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Circular RNAs (circRNAs) regulate gene expression and biological procedures by controlling target genes or downstream pathways by sponging their related miRNA (s). Three types of circRNAs have been identified; exonic circRNAs (ecircRNAs), intronic RNAs (ciRNAs), and exon-intron circRNAs (ElciRNAs). It is clarified that altered levels of circRNAs have dynamic pathological and physiological functions in kidney diseases. Evidence suggests that circRNAs can be considered novel diagnostic biomarkers and therapeutic targets for renal diseases. Glomerulonephritis (GN) is a general term used to refer to a wide range of glomerular diseases. GN is an important cause of chronic kidney diseases. Here, we review the biogenesis of circRNAs, and their molecular and physiological functions in the kidney. Moreover, the dysregulated expression of circRNAs and their biological functions are discussed in primary and secondary glomerulonephritis. Moreover, diagnostic and therapeutic values of circRNAs in distinguishing or treating different types of GN are highlighted.
引用
收藏
页码:568 / 580
页数:13
相关论文
共 50 条
  • [21] Circular RNAs: Novel Biomarkers in Spermatogenesis Defects and Male Infertility
    Saberiyan, Mohammadreza
    Karimi, Elham
    Safi, Amir
    Movahhed, Parvaneh
    Dehdehi, Leila
    Haririan, Nazanin
    Mirfakhraie, Reza
    REPRODUCTIVE SCIENCES, 2023, 30 (01) : 62 - 71
  • [22] Circular RNAs: Novel biomarkers for cervical, ovarian and endometrial cancer
    Shi, Yuchuan
    He, Runhua
    Yang, Yu
    He, Yu
    Shao, Kang
    Zhan, Lei
    Wei, Bing
    ONCOLOGY REPORTS, 2020, 44 (05) : 1787 - 1798
  • [23] Circular RNAs as novel regulators, biomarkers and potential therapies in fibrosis
    Jiang, Xiaoying
    Ning, Qilan
    EPIGENOMICS, 2019, 11 (09) : 1107 - 1116
  • [24] Circular RNAs as Biomarkers for Cancer
    Xia, Lu
    Song, Meiyi
    Sun, Mengxue
    Wang, Fei
    Yang, Changqing
    CIRCULAR RNAS: BIOGENESIS AND FUNCTIONS, 2018, 1087 : 171 - 187
  • [25] Circular RNAs as Urinary Biomarkers
    Lam, W. K. Jacky
    Lo, Y. M. Dennis
    CLINICAL CHEMISTRY, 2019, 65 (10) : 1196 - 1198
  • [26] Circulating long noncoding RNAs as novel biomarkers of human diseases
    Jiang, Xiaoying
    Lei, Ronghui
    Ning, Qilan
    BIOMARKERS IN MEDICINE, 2016, 10 (07) : 757 - 769
  • [27] Exosomal RNAs: Novel Potential Biomarkers for Diseases-A Review
    Wang, Jian
    Yue, Bing-Lin
    Huang, Yong-Zhen
    Lan, Xian-Yong
    Liu, Wu-Jun
    Chen, Hong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [28] Identifying a Novel Role for Circular Tau RNAs in Neurodegenerative Diseases
    Welden, Justin Ralph
    Dockins, Stephen
    Blackburn, Jessica
    Nelson, Peter
    Stamm, Stefan
    FASEB JOURNAL, 2019, 33
  • [29] A narrative review of circular RNAs as potential biomarkers and therapeutic targets for cardiovascular diseases
    Liu, Chi
    Li, Nan
    Dai, Guifeng
    Cavdar, Omer
    Fang, Hong
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (07)
  • [30] Circular RNAS: novel biomarkers of disease activity in systemic lupus erythematosus?
    Cortes, Raquel
    Forner, Maria J.
    CLINICAL SCIENCE, 2019, 133 (09) : 1049 - 1052